TEVA · Teva Pharmaceutical Industries Ltd
$36.77
+0.25 (+0.68%)
At close · Aug 14
Market Cap
$42.85B
Shares
1.17B
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$2,100,000,000
as of 2017-12-31
· not restated in filings since 2018-02-12
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2017-12-31 | $0 | 10-K, filed 2018-02-12 |
| 2016-12-31 | $0 | 10-K, filed 2018-02-12 |
| 2015-12-31 | $439,000,000 | 10-K, filed 2018-02-12 |
| 2014-12-31 | $500,000,000 | 20-F, filed 2017-02-15 |
| 2013-12-31 | $497,000,000 | 20-F, filed 2016-02-11 |
| 2012-12-31 | $1,161,000,000 | 20-F, filed 2015-02-09 |
| 2011-12-31 | $899,000,000 | 20-F, filed 2014-02-10 |
| 2010-12-31 | $99,000,000 | 20-F, filed 2013-02-12 |
| 2009-12-31 | $0 | 20-F, filed 2012-02-17 |
| 2008-12-31 | $0 | 20-F, filed 2011-02-15 |
| 2007-12-31 | $152,000,000 | 20-F, filed 2010-02-22 |
Key facts
CIK
818686
CUSIP
881624209
13F (30d)
623 filings
607 filers
Visit website
Investor relations